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Abstract
Visceral leishmaniasis is associated with significant changes in hematological function but
the mechanisms underlying these changes are largely unknown. In contrast to nawve mice,
where most long-term hematopoietic stem cells (LT-HSCs; LSK CD150+ CD34- CD48-
cells) in bone marrow (BM) are quiescent, we found that during Leishmania donovani infec-
tion most LT-HSCs had entered cell cycle. Loss of quiescence correlated with a reduced
self-renewal capacity and functional exhaustion, as measured by serial transfer. Quiescent
LT-HSCs were maintained in infected RAG2 KO mice, but lost following adoptive transfer
of IFNȖ-sufficient but not IFNȖ-deficient CD4+ T cells. Using mixed BM chimeras, we es-
tablished that IFNȖ and TNF signalling pathways converge at the level of CD4+ T cells.
Critically, intrinsic TNF signalling is required for the expansion and/or differentiation of path-
ogenic IFNȖ+CD4+ T cells that promote the irreversible loss of BM function. These finding
provide new insights into the pathogenic potential of CD4+ T cells that target hematopoietic
function in leishmaniasis and perhaps other infectious diseases where TNF expression and
BM dysfunction also occur simultaneously.
Author summary
Visceral leishmaniasis (VL) in a chronic often fatal disease caused by the protozoan para-
sites Leishmania donovani and L. infantum. Progressive disease in humans and in animal
models is associated with parasite replication at systemic sites, including the bone marrow
(BM) and results in significant changes in hematological profile. The mechanisms under-
lying hematologic dysregulation during infection are largely unknown. Using a panel of
stem cell markers, we characterized murine haematopoietic stem and precursor cells in
the BM over the course of L. donovani-infection in C57BL/6 (B6) mice. Most long-term
hematopoietic stem cells (LT-HSCs) in naïve mice are found in a quiescent state, repre-
senting cells with the highest degree of reconstitution potential. In contrast, during L.
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donovani infection, most LT-HSCs had entered cell-cycle and this correlated with a
reduced potential to engraft into syngeneic recipients. HSC exhaustion and other alter-
ations in the hematopoietic compartment did not occur in infected immunodeficient
mice, but adoptive transfer of IFNč-sufficient CD4+ T cells restored this phenotype. Using
mixed BM chimeras, we established that IFNč signalling and TNF signalling pathways
converge at the level of BM CD4+ T cells, with intrinsic TNF signalling being critical for
the expansion / differentiation of CD4+ T cells that are responsible for HSC exhaustion.
Contrary to commonly held views, in the setting of experimental visceral leishmaniasis
neither IFNč nor TNF signalling in HSCs was required for their functional exhaustion.
Hence, pro-inflammatory cytokines commonly associated with host protection in leish-
maniasis and many other infectious diseases can also drive the development of pathogenic
CD4+ T cells that cause long term irreversible alterations in HSC function.
Introduction
T cells reside in bone marrow (BM) and comprise 4–8% of total BM cells. Recent studies have
indicated that the BM is a preferential site for homing and persistence of memory T cells that
have a high proliferative potential following second encounter with a cognate antigen [1, 2].
Furthermore, alterations in BM T cells have been reported in patients suffering from BM fail-
ure syndromes [3] and in experimental models for aplastic anaemia [4, 5]. However, the func-
tion(s) of the BM T cell compartment are relatively poorly understood compared to their
counterparts in lymphoid tissues, particularly so in the context of infectious diseases where
pathogens themselves reside in the BM. An association between alterations in hematopoietic
function and changes in BM T cells has been described in mice infected with Ehrlichia muris
[6, 7], but mechanistic insight into these processes has been limited.
Hematopoiesis is a strictly regulated process that depends on a small pool of Long-term
hematopoietic cells (LT-HSCs), which have self-renewal capacity and the potential to give
rise to all mature blood cells during the lifespan of an individual. According to the classical
pathway of hematopoiesis, LT-HSCs differentiate into short-term hematopoietic stem cells
(ST-HSCs) that differentiate into a heterogeneous group of multipotent progenitors (MPPs).
LT-HSCs, ST-HSCs and MPPs are contained within the LSK population, so called for their
lack of expression of mature blood cell-associated markers (Lineage negative) and their expres-
sion of Sca1 and cKit. MPPs give rise to intermediary progenitors, the common lymphoid pro-
genitors (CLPs) and the common myeloid progenitors (CMPs), the latter subsequently giving
rise to both granulocyte/macrophage progenitors (GMPs) and megakaryocytic/erythrocyte
progenitors (MEPs) [8]. Non-committed and lineage-committed progenitors are collectively
defined as hematopoietic stem and progenitor cells (HSPCs).
The integration of systemic and local signals by HSPCs has been suggested to be one mech-
anism that allows these cells to respond to infection and subsequently help regulate immune
effector function [9]. In contrast, prolonged activation and proliferation of HSCs has been
associated with functional exhaustion in several infection models [7, 10, 11], and may underlie
the association between chronic infection and hematological dysfunction, as commonly de-
scribed in humans [12]. The immune mechanisms associated with HSC exhaustion and
whether these operate in an HSC-intrinsic manner or reflect alterations in the BMmicroenvi-
ronment remain important unanswered questions.
Visceral leishmaniasis (VL), caused by infection with the obligate intracellular parasites
Leishmania donovani and L. infantum is characterized by parasite accumulation in systemic
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PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006465 July 3, 2017 2 / 24
and analysis, decision to publish, or preparation of
the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
tissues, including BM, and clinical signs including hypergammaglobulinaemia, hepato-spleno-
megaly and disturbances in blood homeostasis, including anemia, thrombocytopenia, leucope-
nia and neutropenia [13–15]. The infection is fatal without drug treatment and even treated
patients may die from bleeding or opportunistic bacterial infections [16, 17]. In humans,
splenic sequestration and ineffective haematopoiesis have been suggested as possible causes to
explain peripheral cytopenia, and noted alterations in the BM include erythroid hyperplasia,
increased plasma cells, increased frequency of granulocytic and megakaryocyte immature
forms, and histiocytic hyperplasia [15]. Furthermore, several clinical reports have described
pancytopenia in VL patients followed by a multilineage myelodysplasia reminiscent of true
myelodysplastic syndrome (MDS), suggesting the presence of ineffective haematopoiesis [18–
20].
Experimental rodent models have been extensively used to study the immunopathology of
VL, also reporting alterations in hematopoietic function. For example, L. donovani infection
in BALB/c mice is associated with increased numbers of hematopoietic precursor cells, as
assessed by colony-forming units in culture [21], and both mice and hamsters show various
degrees of cytopenia and changes in BM cellularity following infection [22, 23]. Here, we dem-
onstrate that L. donovani infection in mice drives LT-HSCs into active proliferation at the
expense of cells in quiescence, leading to functional exhaustion. Importantly, this response was
dependent upon increased numbers of IFNč-producing CD4+ T cells with resident effector
function in the BM of infected mice, but not on HSC-intrinsic IFNč signalling. Unexpectedly,
we found that expansion of BM effector T cells was regulated by T cell-intrinsic TNF receptor
signalling, indicating a novel means by which TNF and IFNč signalling pathways cooperate
and converge at the level of CD4+ T cells to effect long-lasting impairment of hematopoietic
function during infection.
Results
L. donovani infection results in an increase in BM multipotent non-
committed progenitors
We first characterised the impact of L. donovani infection (Fig 1A and 1B) on BMHSPCs
using a panel of markers [8] (S1 Table; Fig 1C). In this analysis, we allowed for the finding
that Sca1 is up-regulated on all progenitors after infection [6, 24], leading to a deficiency in
the cKit+ Sca1- and cKit- Sca1- cell populations compared to naïve mice (Fig 1D). Infection
resulted in a significant increase in the number of multipotent Lineage- cKit+ Sca1+ precursors
in the BM that mirrored the course of infection and peaked on d28 post infection (p.i.) (Fig
1E). CD48 has been associated with a loss of stemness amongst LT-HSC [25–28]. Hence, we
further characterised LSK CD150+CD34- cells on the basis of CD48 expression. The number
of LSK CD150+CD34-CD48- cells (enriched for LT-HSCs) was unaltered in d28-infected mice
compared to uninfected mice. In contrast, the numbers of LSK CD150+CD34-CD48+ cells and
LSK CD150+CD34+ cells were significantly increased (Fig 1F). Notably, this increase in non-
committed progenitors was not matched by increased numbers of lineage-committed precur-
sors (Fig 1G), suggesting the possibility that HSPC differentiation was inhibited. Collectively,
these findings indicate that infection had induced changes in hematopoietic differentiation
prior to lineage commitment.
Depletion of quiescent HSCs is a consequence of L. donovani infection
To evaluate whether L. donovani infection affected the function of HSPCs, we used a competi-
tive adoptive transfer model. We selected this approach because it allows for the evaluation of
Pathogenic BM CD4+ T cells in leishmaniasis
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Fig 1. L. donovani infection increases the number of non-committed multipotent progenitors in BM. (A) Spleen
parasite burden (LDU). (B) BM parasite burden. (C) Diagram of stepwise differentiation of hematopoietic precursors and
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the function of progenitor cells derived from infected and non-infected hosts in the same envi-
ronment. Although long-term in vitro cultures are able to quantify more primitive progeni-
tors, the growth factors required for LT-HSCs and their immediate progeny are not well
established and may, therefore, impact the differentiation process [29].
BM lineage negative cells (enriched for HSPCs) from day 28 infected B6.CD45.2 mice and
from uninfected B6.CD45.1 mice were mixed 50:50 and transferred into non-infected x-irradi-
ated (B6.CD45.1 x B6.CD45.2)F1 recipients and cellularity assessed seven weeks later (Fig 2A;
S1A Fig). HSPCs from infected mice contributed 21.81% ± 11.27 total donor cells in the BM
of recipient mice and 24.76% ± 2.43 of total splenocytes (Fig 2B). Hence, HSPCs from infected
mice have reduced competitiveness compared to HSPCs derived from naïve mice. No sig-
nificant differences were noted in the frequency of B cells, T cells and CD11b+myeloid cells,
however, indicating that lack of HSPCs competitiveness was not associated with any evident
lineage bias (Fig 2C). This was reflected in the similar frequencies of BMmultipotent pro-
genitors (Fig 2D) and lineage committed precursors (Fig 2E) derived from HSPCs from
infected and naive mice. To determine whether LT-HSC might be infected with L. donovani,
we infected mice for 28 days with Td-Tomato transgenic L. donovani and examined BM cells
for the presence of amastigotes by flow cytometry. Although we observed that a very small
percentage of BM lineage negative cells were infected with L. donovani, we did not observe
infection of LT-HSCs (S1E Fig), ruling out infection of LT-HSCs as a reason for their altered
competitiveness. These data suggested that infection results in HSC-intrinsic functional im-
pairment that occurs prior to lineage commitment.
To test this hypothesis, we initially performed a long-term non-competitive adoptive transfer
experiment, placing LSK CD150+ CD34- CD48- cells (LT-HSCs) from CD45.2 naive or infected
mice into naive CD45.1 recipients (Fig 2F). Donor LT-HSCs from infected mice showed a
trend towards poorer reconstitution in BM (2.72 x 107 ± 1.41 x 107 cells vs. 6.96 x 106 ± 7.89 x
106 cells, naive vs. infected mice), and the same was observed in the spleen (Fig 2G). We could
not detect any significant alteration in the distribution of mature spleen cells derived from
infected compared to naive donor cells, again suggesting no lineage bias arises from HSCs from
infected mice (S1B Fig). However, the number of LSK cells and LSK CD150+ FLT3- CD34- cells
(enriched in LT-HSCs) derived from infected donors was significantly decreased compared to
naïve donors (Fig 2H), again indicating that HSCs from infected mice were less able to reconsti-
tute the hematopoietic system and their self-renewal potential was compromised.
To further investigate the long-term reconstituting potential and to more accurately evalu-
ate the reduction in functional capacity of HSCs from infected mice, we transferred 50 LSK
CD150+ CD34- CD48- cells that were isolated from the primary adoptive transfer recipients
into secondary recipients (Fig 2F). We identified BM and spleen cells in all (4/4) recipients of
LT-HSCs originally obtained from naive mice. In contrast, only 2/3 BM and 2/3 spleens exam-
ined had detectable cells derived from HSCs originally taken from infected mice and these
were very rare in number (Fig 2I). In all secondary recipient mice transplanted with LT-HSCs
isolated from non-infected mice, we could detect donor HSPCs for the three lineages in the
BM of recipient mice and, following an overall period of 40 weeks of transfer into healthy
panel of associated surface molecular markers used to characterize the different hematopoietic stem and progenitor cells
(HSPCs). (D) Relative number of LSK CD150+Flt3- CD34- cells, LSK CD150+Flt3-CD34+ cells and LSK CD150-Flt3+CD34+
cells (Mean  SD, normalized to average number calculated in nawve mice for two femurs and two tibias). *p 0.05, **p
0.01, ***p0.001, by one-way ANOVA and Dunnett’s Multiple Comparison Test (n = 4). (E) Number of progenitors
separated by CD48 expression in BM of nawve and d28-infected mice (Ld28) (F) Number of lineage committed progenitors,
as in (E). Three independent experiments (n = 8–12); Data presented as scatter plot and mean bar; *p 0.05, **p0.01,
***p0.001, ****p0.0001 by unpaired t test. (G) Representative dot plots showing Sca1 and cKit expression on BM
lineage negative cells for naive (left) and d28-infected mice (right).
https://doi.org/10.1371/journal.ppat.1006465.g001
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Fig 2. HSPCs from infected mice have defective capacity for self-renewal. (A) Diagram of experimental
layout: nawve lethally irradiated B6.CD45.1xCD45.2 (n = 4) recipients received a 50:50 mix of BM Lin- cells
Pathogenic BM CD4+ T cells in leishmaniasis
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recipients, LT-HSCs derived from naive donors were capable of self-renewal and of giving rise
to all lineages. In contrast, we only found LSK CD150+ CD48- cells derived from infected
donors in 1/3 recipients and we failed to find lineage-committed progenitors or mature prog-
eny in 2/3 recipients (Fig 2J, S1C and S1D Fig). Collectively, these data suggested that HSCs
from infected mice show intrinsic long-term functional impairment.
In naïve mice, LT-HSCs are commonly found in G0 (Ki67-), and a strict regulation of
LT-HSC proliferative status is required for the maintenance of long-term self-renewal and
multi-lineage differentiation potential [30, 31]. We found that approximately 40% of LT-HSCs
in naïve mice expressed Ki67 (Fig 3A and 3D). At day 28 p.i., however, the frequency of
LT-HSCs in cell-cycle was significantly increased (96.52% ± 3.19) (Fig 3A and 3D). Onward
populations of non-committed progenitors were highly proliferative both in naïve and infected
mice, and following infection these resulted in an increased number of LSK CD150+ CD34-
CD48+ Ki67+ cells and LSK CD150+ CD34+ Ki67+ cells in infected mice (90-fold and 4.8-fold,
respectively, compared to naive mice) (Fig 3Ai and 3B). Furthermore, the loss of LSK CD150+
CD34- CD48- Ki67- cells during infection represented a 24-fold decrease in number (from
831 ± 0.017 to only 34.62 ± 31.93 cells in total BM; Fig 3C). Hence, depletion of the reservoir
of LT-HSCs due to proliferation may account for poor reconstitution efficiency shown by
HSPCs from infected mice.
To determine the mechanisms regulating proliferation, we assessed the expression of the
transcription factor GATA-3, as recent studies have suggested that GATA-3 is important in
the regulation of HSC proliferative status and self-renewal potential during stress-induced
hematopoiesis [32, 33]. We observed an infection-associated increase in GATA-3 expression
in most immature cells (S2A Fig). We next determined whether the expression of GATA-3
could be related to the proliferative state of LSK CD150+ CD48- cells. Few cells in G0 expressed
GATA-3 but concomitant with infection, we observed a significant increase in LSK CD150+
CD48- cells expressing Ki67 and GATA-3 (17.64 ± 11.23 vs. 46.68 ± 21.66, in naive vs. infected
mice, respectively) (S2B Fig), and in infected mice we determined a significant alteration in
the distribution of LSK CD150+ CD48- cells segregated according to the expression of GATA-
3 and Ki67 (S2B Fig). As such, GATA-3 over expression due to inflammation may represent a
mechanism for impaired maintenance of homeostatic numbers of quiescent LT-HSCs during
L. donovani chronic infection.
Accumulation of “effector” BM CD4+ T cells is associated with altered
LT-HSC function
In contrast to wild type (WT) B6 mice, immunodeficient Recombination activating gene 2
(Rag2) knockout mice showed no signs of infection-associated changes in HSPCs, despite a
significantly higher parasite burden (Fig 4A and 4C). Furthermore, infection of Rag2 KOmice
from d28-infected B6.CD45.2 and nawve B6.CD45.1 mice (A-D); (B) Frequency of donor hematopoietic cells in
BM and spleen of recipient mice at 12 weeks post BMT; (C) Frequencies of donor leucocytes in spleen; (D)
Frequencies of donor non-committed hematopoietic progenitor cells in BM; (E) Frequencies of lineage-
committed progenitors in BM derived from each donor. (F) Diagram of experimental layout: nawve lethally
irradiated B6.CD45.1 recipients received a radioprotective dose of 3x105 CD45.1 cells along with 160 HSCs
isolated from nawve or d28 infected B6.CD45.2 mice (F-H). (G) Number of donor hematopoietic cells in the BM
and in the spleen of recipient mice at 16 weeks post BMT; (H) Number of donor non-committed multipotent
progenitors cells in the BM of recipient mice. (I-J) Nawve irradiated B6.CD45.1 recipients received a radio
protective dose of 3x105 CD45.1 cells along with 50 HSCs of each origin derived from recipients (n = 3–4 per
group) as shown in (F); (I) Number of donor hematopoietic cells in the BM and spleen of recipient mice at 24
weeks post BMT; (J) Number of donor non-committed multipotent progenitors cells in BM. Data presented as
scatter plot and mean bar; *p 0.05, **p0.01, ***p0.001, ****p0.0001 by unpaired t test.
https://doi.org/10.1371/journal.ppat.1006465.g002
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did not deplete the reservoir of quiescent HSCs (Fig 4B), suggesting a central role for adaptive
immunity as a driver of these effects in immunocompetent mice.
In WTmice, we found that BM CD4+ T cells increased in number 24-fold on infection,
whereas CD8+ T cells increased ~2-fold (Fig 5A). To determine if these BM CD4+ T cells were
phenotypically similar to the recently described BM resident effector cells, we examined the
expression of CD44, CD127 and Ly6C [1, 34]. In the BM, a majority of CD4+ T cells were
CD44high cells, increasing from 72.22% ± 8.67 of total CD4+ T cells in naive mice to 93.56% ±
1.39 in infected mice. The most abundant population of CD4+ T cells was CD44high Ly6C-/low
CD127-/low (“effector T cells”) (Fig 5B), consistent with the accumulation of effector CD4+ T
cell in BM during infection with L. donovani.
To characterize their potential for cytokine production, we used in vitro stimulation with
PMA and ionomycin followed by flow cytometry (Fig 5C–5K). The frequency of BM CD4+ T
cells capable of producing IFNč within the total BM was very low (0.10% ± 0.05) in naive mice,
but increased following infection (7.64% ± 3.57 of total BM cells; Fig 5C). The percentage of
CD8+ T cells with the potential to produce IFNč also increased in the BM of infected mice but
Fig 3. Loss of quiescent LT-HSCs following L. donovani infection. (A and B) Frequency (A) and number (B) of Ki67+ within HSPCs populations in BM
of nawve and d28-infected B6 mice. (C) Number of LT-HSCs in G0 (Ki67-) in BM in nawve and d28-infected mice (n = 12 per group; three independent
experiments). Data presented as scatter plot and mean bar; unpaired t test; *p 0.05, **p0.01 ****p0.0001. (D) Representative dot plots for Ki67
expression on LSK CD150+CD34-CD48- cells.
https://doi.org/10.1371/journal.ppat.1006465.g003
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to a lesser extent (0.24% ± 0.14 vs 1.16% ± 1.03, naive vs. infected), and there was no indication
of other relevant sources of IFNč (Fig 5C). Within the CD4+ T cell population of infected
mice, 82.06% ± 14.23 of cells had the potential to produce IFNč compared to 17.33% ± 8.95 in
naive controls (Fig 5E and 5K), and a significant increase in the frequency of cells expressing
IFNč driven by L. donovani infection was also determined directly ex vivo (Fig 5F and 5K).
Analysis of the MFI for INFč+ within CD4+ T cells also demonstrated an increase in cytokine
production on a per cell basis, compared to CD4+ T cells from naive mice (Fig 5I). Similar
data were also obtained for TNF production by BM CD4+ T cells (Fig 5D, 5G, 5H and 5J).
Overall these data show that L. donovani infection stimulated marked recruitment / expansion
of highly active BM effector CD4+ T cells.
CD4+ T cells mediate LT-HSC exhaustion via INFȖ-dependent
mechanisms
We hypothesized that BM CD4+ T cells might drive the alterations observed in the hematopoi-
etic compartment during infection. To assess whether this was the case, Rag2 KOmice were
Fig 4. Quiescent LT-HSCs are retained in infected Rag2-/- mice. (A) Number of HSPCs in BM of nawve B6.WT (light squares), nawve B6.Rag2-/- (dark
grey triangle), d28 infected B6 (dark grey squares) and d28 Rag2-/- (light grey circles) mice. (B) Number of BM LT-HSCs in G0 (Ki67-). (C) Spleen parasite
burden in B6.WT and B6 Rag2-/-, presented as number of parasites per 1000 nuclei. Data from three independent experiments presented as scatter plot
and mean bar (n = 9–16 per group); *p 0.05, **p0.01, ***p0.001 and ****p0.0001; unpaired t test.
https://doi.org/10.1371/journal.ppat.1006465.g004
Pathogenic BM CD4+ T cells in leishmaniasis
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Fig 5. L. donovani infection expands the population of BM T cells expressing IFNȖ and TNF. Comparison of BM T
cells in nawve and d28-infected mice (Ld28). (A) Number of T cells in BM. (B) Frequency of total CD44high and CD44high
Pathogenic BM CD4+ T cells in leishmaniasis
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adoptively transferred with sorted CD4+ T cells from naive B6 mice, and then infected with L.
donovani (Fig 6A). The number of LT-HSCs was unchanged in all three groups (Fig 6B),
whereas the number of intermediary non-committed progenitors (LSK CD150+CD34-CD48+
cells and LSK CD150+CD34+ cells) increased in adoptively transferred Rag2 KOmice to a sim-
ilar extent as observed in infected WTmice (Fig 6C and 6D). More importantly, we found
that whereas infected Rag2 KOmice preserved their reservoir of quiescent LT-HSCs, this was
reversed following CD4+ T cell transfer (Fig 6E). In contrast, adoptively transferred Rag2 KO
mice that were not infected retained their full quiescent HSPC pool, indicating that infection
rather than homeostatic expansion of CD4+ T cells is required to drive LT-HSCs out of quies-
cence (Fig 6F and 6G). As IFNč signalling has been associated with altered HSC function [6,
7, 10, 11, 35], we assessed the competency of IFNč-/- CD4+ T cells to regulate loss of quiescence
in infected Rag2 KO recipients. All effects attributed to the transfer of CD4+ T cells to Rag2
KO recipients described above were lost when these cells were incapable of producing IFNč
(Fig 6H and 6I), defining CD4+ T cell-derived IFNč as a critical regulator of LT-HSC function
during L. donovani infection. On the other hand, IFNč was critical to control parasite burden
(Fig 6J), indicating that the mechanisms underlying host resistance to infection may also
impact hematopoietic function when sustained over time.
Intrinsic IFNȖR signalling in HSCs is not required for loss of quiescence
HSCs express receptors for IFNč, which have been directly associated with LSK expansion and
impaired engraftment in X-irradiated hosts [7, 35]. To test whether LT-HSC intrinsic IFNčR
signalling was required for loss of quiescence, we generated 50:50 mixed BM chimeras using
cells derived from both WT and Ifnčr2-/-mice (B6.CD45.1 + B6.CD45.2.Ifnčr2-/-!B6.CD45.1)
(Fig 7A). The percentage of BM cells derived from Ifnčr2-/- donor cells was comparable to WT
donor cells (Fig 7B). In infected recipient mice, the frequency of WT and Ifnčr2-/- LSK
CD150+ CD48- cells in the BM was similar, as was the increase in frequency of LSK CD150+
CD48+ cells derived fromWT donor cells and Ifnčr2-/- donor cells (Fig 7C). Most importantly,
loss of quiescent HSCs was observed equally for WT and Ifnčr2-/- derived cells (Fig 7D). Thus,
intrinsic IFNč signalling was not mediating the expansion of multipotent progenitors or
LT-HSC exhaustion in this model.
Nonetheless, significant changes in the frequency of myeloid progenitors and mature mye-
loid cells derived fromWT and Ifnčr2-/- were observed following infection, suggesting that
IFN-č signalling may modulate the generation of myeloid cells in response to L. donovani
infection (S3A, S3C and S3E Fig). There was no indication that IFNč signalling played a
major role regulating the B cell compartment following infection (S3B and S3D Fig).
Lack of IFNčR2 led to an increase in the frequency of donor cells in the spleen compared to
WT donor cells, suggesting that IFNč signalling impacts on hematopoietic function both in
steady-state and under inflammatory conditions (Fig 7E). In BM and spleen of non-infected
recipient mice, the frequency and absolute number of T cells was comparable between WT
and Ifnčr2-/- donor cells, indicating that IFNč signalling in T cells was not required for their
subsets within total BM CD4+ T cell population. (C) Frequency of IFNȖ+ subsets in total BM cells. (D) Frequency of TNF+
subsets in total BM cells. (E) Frequency of IFNȖ+ within BM CD4+ T cell population following stimulation in vitro. (G)
Frequency of IFNȖ+ within BM CD4+ T cell population directly ex vivo. (H) Frequency of TNF+ within BM CD4+ T cell
population following stimulation in vitro. (I) Mean Fluorescene Intensity (MFI) of IFNȖ in IFNȖ+CD4+ T cells. (J) MFI of TNF
in TNF+CD4+ T cells. Data from at least two independent experiments (n = 6–14 per group) presented as scatter plot and
mean bar; *p 0.05, **p0.01, ***p0.001 and ****p0.0001; unpaired t test. (K) Representative dot plots for IFNȖ
expression by stimulated BM CD4+ T cells (top) or ex vivo (bottom).
https://doi.org/10.1371/journal.ppat.1006465.g005
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Fig 6. CD4+ T cells drive HSC exhaustion in an IFNȖ-dependent manner. (A) Diagram of experimental layout, RAG2 KO mice were
adoptively transferred with sorted CD4+ T cells from naive mice, and then infected in the following day with L. donovani. At day 28 p.i., we
analysed the distribution of hematopoietic progenitors in the BM in nawve RAG mice, infected RAG2 KO mice and infected RAG mice that receive
adoptively transferred CD4+ T cells: (B-E) Number of HSPCs: LT-HSCs (B), LSK CD150+CD34-CD48+ cells (C), LSK CD150+CD34+ cells (D)
Pathogenic BM CD4+ T cells in leishmaniasis
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development or homeostatic maintenance. In contrast, the lack of IFNčR2 intrinsic signalling
prevented the expansion of the T cell compartment following infection that was seen with WT
T cells, both in BM and in the spleen (Fig 7F–7I). As such, intrinsic IFNč signalling confers a
proliferative or survival advantage for CD4+ T cells during L. donovani induced inflammation,
but not under conditions of homeostatic expansion.
and quiescent LT-HSCs LSK in BM (E) (n = 12–17 per group, from three independent experiments). (F) Frequency of HSPCs populations within
Lineage negative cells in nawve RAG mice with and without adoptive CD4+ T cell transfer; and (F) number of quiescent LT-HSCs (n = 9–5 per
group). (H-J) Frequency of progenitor cells within Lineage negative cells in infected RAG mice without or with adoptive transfer of IFNȖ sufficient
or IFNȖ-deficient CD4+ T cells (G); Number of quiescent LT-HSCs (n = 4–5) (H). (J) Parasites per 1000 nuclei in the spleen. Data presented as
presented as scatter plot and mean bar; *p 0.05, **p0.01, ***p0.001 and ****p0.0001; one-way Anova and Tukey’s multiple
comparisons test.
https://doi.org/10.1371/journal.ppat.1006465.g006
Fig 7. Intrinsic IFNȖ receptor signaling is required for expansion of BM T cells following infection. (A) Experimental design
for competitive mixed BM chimeras using wild-type (WT) and IfnȖr2 knockout (IFNȖR2 KO). Analyses were performed 12 weeks
after BMT from CD45.2 Ifnr2-/- mice and CD45.1 WT mice (50:50) to lethally irradiated CD45.1 recipient mice, subsequently
infected with L. donovani for 28 days. (B) Frequency of donor cells in BM. (C) Frequency of BM LSK CD150+ CD48- cells (enriched
for LT-HSCs) and LSK CD150+ CD48+ cells within donor cells. (D) Frequency of LT-HSCs in G0 (Ki67-) within donor cells. (E)
Frequency of donor cells in spleen. (F) Frequency of T cells within donor cells in spleen. (G) Number of donor T cells in spleen. (H)
Frequency of BM T cells within donor cells. (I) Number of donor T cells in the BM. Data presented as scatter plot and mean bar
(n = 4–8); *p 0.05, **p0.01, ***p0.001 and ****p0.0001; One-way Anova followed by Tukey’s multiple comparisons test.
https://doi.org/10.1371/journal.ppat.1006465.g007
Pathogenic BM CD4+ T cells in leishmaniasis
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006465 July 3, 2017 13 / 24
Intrinsic TNFR signalling modulates expansion of BM CD4+ T cells
TNF has also been proposed to play an important role in directly modulating HSC function
and may cooperate with other mechanisms in driving stress-induced hematopoiesis and medi-
ating hematopoietic dysfunction [36]. Non-committed progenitors upregulated the expression
of receptors for TNF (TNFR1a and TNFR1b) during L. donovani infection (S4 Fig). To for-
mally test whether intrinsic TNF signalling plays a role in driving LT-HSCs into active cell-
cycle and subsequent LT-HSC exhaustion, we transferred equal numbers of BM cells fromWT
and Tnfrsf1-dKO donors into lethally irradiated recipients (Fig 8A). In naïve chimeras assayed
at 13 weeks post BM transfer (BMT), Tnfrsf1-dKO cells showed a clear competitive advantage
(representing 68.51% ± 7.58 of total cells in BM; Fig 8B). This was also observed in the spleen
and suggested that TNF signalling may modulate hematopoietic function during homeostasis.
Although minor changes in relative frequency occurred following infection, the bias towards
Tnfrsf1-dKO cells was not enhanced (Fig 8B). Loss of both TNFRs had no impact on the
expansion of LSK cells (Fig 8C) or on the loss of quiescent LT-HSCs (Fig 8D). Minor changes
were observed in the lineage-committed progenitors, B cells and CD11b+ cells in the BM and
spleen of infected recipients (S5A, S5B, S5C and S5D Fig). These data argue against a role for
LT-HSC intrinsic TNF signalling in the expansion of multipotent progenitors and in LT-HSC
exhaustion.
Remarkably, in non-infected chimeric mice, the frequencies and number of total BM T
cells and BM CD4+ T cell derived fromWT and Tnfrsf1-dKO donor cells were similar, whereas
following infection differences in T cells derived fromWT and Tnfrsf1-dKO donor cells
became evident in the BM. Tnfrsf1-dKO CD4+ T cells did not increase in frequency or number
following infection, whereas WT CD4+ T cells expanded approximately 15-fold (Fig 8E and
8F). Likewise, in the spleen WT T cells but not Tnfrsf1-dKO T cells increased in frequency and
number, although to a lesser extent than in the BM (S5E and S5F Fig). Thus, TNF acts directly
on BM CD4+ T cells to regulate their expansion following infection.
Loss of TNFR signalling prevents expansion of IFNȖ-producing BM
CD4+ T cells
As the expansion of BM CD4+ T cells following infection was prevented in cells lacking TNF
signalling receptors, we used the mixed chimeras described above to assess whether T cells
devoid for TNF signalling were impaired in their efficiency to produce IFNč, a cytokine critical
in regulating LT-HSC exhaustion (Fig 6). In the BM of these infected mice, 2.29x 106 ±
7.67x105WT CD4+ T cells had the potential to express IFNč compared to 7.87x104 ± 3.07x104
Tnfr1/Tnfr2 double KO donor cells (Fig 8G). This disparity betweenWT and Tnfr1/Tnfr2 dou-
ble KO donor CD4+ T cells was further amplified in terms of absolute number of IFNč produc-
ing cells analysed directly ex vivo (Fig 8H). TNFR deficiency also impacted on the ability of
CD8+ T cells to produce IFNč, although their contribution to the overall level of this cytokine
in BM was minor (Fig 8G and 8H). Collectively these data demonstrate that TNF acting
directly on CD4+ T cells is required for the accumulation of a pathogenic population of CD4+
T cells expressing IFNč in BM, which in turn mediates exhaustion of HSCs in mice infected
with L. donovani.
Discussion
Although it is well established that impairment of hematological function occurs during VL,
the underlying mechanisms are poorly understood [15]. In the current study, we demonstrate
that CD4+ IFNč+ effector T cells expand in the BM of L. donovani infected mice and drive
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LT-HSCs into a state of functional exhaustion. Our data define a new pathogenic role of CD4+
T cells in this disease model, and describe a novel TNF signalling-dependent pathway for regu-
lating effector T cells that may also have relevance for other diseases characterised by hemato-
logical dysfunction.
In the current study, we have focused on early events in hematopoiesis examining the fate
and self-renewal potential of LT-HSCs in mice. We have identified for the first time that fol-
lowing L. donovani infection early hematopoietic progenitors accumulate in BM due to an
Fig 8. T cell intrinsic TNF receptor signaling is required the expansion of pathogenic CD4+ T cells following
infection with L. donovani. (A) Experimental design for competitive mixed BM chimeras using wild-type (WT) and
Tnfrsf1-dKO (TNFdRKO), subsequently infected with L. donovani for 28 days. Analyses were performed 13 weeks after
BMT from CD45.2 TNF-RdKO mice and CD45.1 WT mice (50:50) to lethally irradiated CD45.1 recipient mice. (B)
Frequency of donor cells in BM and spleen. (C) Frequency of HSPCs within donor cells in BM. (D) Frequency of BM
LSK CD150+ CD48- cells (enriched for LT-HSCs) in G0 (Ki67-) within donor cells. (E) Frequency of total BM T cells and
BM CD4+ T cells within donor cells. (F) Number of T cells and CD4+ T cells in BM. (G) Number of BM leucocytes
expressing IFNȖ in nawve and infected mice derived from B6 or Tnfrsf1-dKO donor HSCs following PMA/ionomycin
stimulation in vitro. (H) Number of BM T cells and BM CD4+ T cells IFNȖ+ cells derived from B6 or Tnfrsf1-dKO donor
HSCs measured directly ex vivo. *p 0.05, **p0.01, ***p0.001 and ****p0.0001; One-way Anova followed by
Tukey’s multiple comparisons test.
https://doi.org/10.1371/journal.ppat.1006465.g008
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increase in active proliferation, but at the expense of the reservoir of quiescent LT-HSCs. We
found that alteration in the proliferative status of LT-HSCs was associated with the upregula-
tion of the expression of GATA-3, a transcription factor previously associated with loss of
reconstitution potential of HSCs [37], and confirmed loss of self -renewal capacity through
serial transfer. As residual HSC function was reflected by multilineage differentiation, within
the constraints of our analysis, the impact of infection with L. donovani does not appear to
extend to the epigenetic effects that have been reported in aging and some hematological
malignancies [38].
Our findings are in agreement with and extend previous studies that have reported alter-
ations in the proliferative status and self-renewal capacity of LT-HSCs under pro-inflamma-
tory conditions [10, 11, 33, 35, 39]. Similar alterations in HSC behaviour have also been
described in other models of infection although a consensus on whether this is host beneficial
or detrimental has not been reached [7, 24, 40, 41]. Unlike here, previous studies have not pro-
vided a causal link between changes in cytokine profile, T cell response and HSC exhaustion.
A role for T cells has, however, been mooted. Using experimental models for aplastic anemia,
T cells were proposed as key mediators of hematopoietic dysfunction and ultimately BM fail-
ure [4, 5], and in experimental ehrlichiosis, infection-induced expansion of LSK cells was
shown to be dependent upon IFNč production by CD4+ T cells [7].
We found clear alterations in the composition of T cells residing in the BM following infec-
tion, notably a dramatic increase in the frequency and number of CD4+ T cells displaying an
“effector” phenotype and secreting high levels of IFNč. Antigen-specific CD4+ T cells produc-
ing IFNč are a well characterised feature of VL, both in murine models and in humans and
play an important role in immune protection [42–44]. However, this is the first report address-
ing the profile of cytokine expression in BM CD4+ T cells following experimental L. donovani
infection. In adoptive transfer settings, the production of IFNč by CD4+ T cells was sufficient
to drive LT-HSC exhaustion defining this pro-inflammatory cytokine as a key regulator of
hematopoiesis during infection with L. donovani. Strikingly, the absence of CD4+ T cell-intrin-
sic TNF signalling prevented their expansion in the BM of infected mice, and limited their
potential to produce IFNč, indicating that TNF plays a central upstream role in regulating the
BM T cell compartment during infection. Although evidence of T cell function in the BM of
patients with VL is scare, available data also suggests that IFNč is more abundant in BM aspi-
rate fluid than in serum in active VL patients and that higher than baseline levels of IFNč per-
sist in BM post cure [45].
Alterations in the proliferative status of HSCs and their subsequent functional impairment
have been linked to IFNč in other situations of stress-induced hematopoiesis, and it has been
suggested that this reflects the effects of direct HSC-intrinsic IFNčR signalling [10, 11, 46].
Thus, IFNčR-signalling on HSCs has been viewed as a pivotal mechanism to explain alter-
ations in HSC function under inflammatory conditions [47–50]. Likewise, a similar role was
more recently suggested for HSC-intrinsic TNFR signalling during stress-induced hemato-
poiesis [36]. To test the hypothesis that IFNč signalling and/or TNFR signalling in LT-HSCs
were driving increased proliferation during infection with L. donovani, we established BM
mixed chimeras with equal number of total BM cells derived fromWT and IFNčR2KO or
TNFRdKO. This approach allowed the experimental evaluation of the impact of IFNčR and
TNFR signalling in LT-HSCs, whilst excluded the confounding effect of global loss of IFNč or
TNF signalling evident in previous studies [10, 11, 46]. Our findings obtained using a mixed
BM chimeric model do not support these conclusions. Rather, our data clearly demonstrate
that LT-HSCs in a cytokine replete environment are driven into exhaustion in an identical
manner, irrespective of whether they express IFNčR2 or TNFR. Our findings strongly suggest
that, in contrast to directly affecting LT-HSCs, IFNčand TNF receptor signalling converge at
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the level of the CD4+ T cells to regulate expansion of a highly-activated effector population.
Further work will be required to establish the cellular target of IFNč produced by BM CD4+ T
cells in L. donovani-infected mice. For example, changes in stromal cell function due to expo-
sure to IFNč have been proposed to explain the increased myelopoiesis in mice infected with
Lymphocytic choriomeningitis virus (LCMV) strain WE [51].
Intrinsic IFNčR signalling has been suggested to regulate T cell differentiation in other set-
tings [52, 53]. For example, in mice immunized with LCMV, it was shown that antigen-specific
CD4+ T cells expand at a much higher rate compared to CD4+ T cells lacking IFNč signalling
[53]. In contrast, in experimental Listeria monocytogenes infection, the expression of IFNč by
CD4+ T cells was negatively regulated by IFNčR [52]. Finally, in mixed BM chimeras infected
with E. chaffeensis, IFNčR-deficient T cells were increased in frequency compared to IFNčR-
sufficient T cells [6], contrary to our observations with L. donovani in similar chimeric mice.
Together, these studies argue for the existence of potentially diverse mechanisms of immune
control that are exaggerated under different infection conditions.
A key finding from our work is the identification of a role for intrinsic TNFR signalling in
CD4+ T cells as a key step in their differentiation into cells able to drive LT-HSC exhaustion.
Following L. donovani infection the lack of intrinsic TNF signalling led to a 30-fold reduction
in the number of BM CD4+ cells expressing IFNč. Therefore, TNF emerges as a crucial media-
tor in the development of this pathogenic population of CD4+ T cells in the BM, as well as in
the spleen, of L. donovani-infected mice. As with studies on the role of IFNčR, the literature is
divided over the role of intrinsic TNFR signalling in CD4+ T cells. For example, a lack of
intrinsic TNF-R1b signalling has been reported to significantly curtail expansion of CD4+ T
cells in response to low concentrations of specific antigen and compromise the ability of T
cells to express IFNč [54], whereas lack of TNF or TNFR signalling lead to uncontrolled expan-
sion of IFNč+ T cells following BCG infection [55, 56].
Compared with the spleen, T cells enriched for an “activated” phenotype reside in greater
numbers in the BM of naive animals ([2, 57]) and persist for much longer periods of time in
BM compared other lymphoid tissues following infection resolution [2, 58]. These data, in
combination with our findings suggest that the development of highly activated BM homing
CD4+ T cells, induced not only by Leishmania infection, but by a variety of infectious chal-
lenges, may account for erosion of hematological function over time. Furthermore, the link
established here between TNF and the development of BM CD4+ T cells with potential to irre-
versibly impact on LT-HSC function may be of importance in other non-infectious diseases
where TNF production and hematological abnormalities co-exist.
In summary, we propose a mechanism (S6 Fig) whereby following infection: (i) IFNč and
TNF produced as part of the ongoing immune response co-operate at the level of receptor sig-
nalling on CD4+ T cells to promote accumulation of highly activated effector CD4+ IFNč+ cells
in the BM; (ii) in these cells, TNF signalling (possibly in association with other mediators)
drive the expression of IFNč; (iii) IFNč produced by CD4+IFNč+ T cells operates indirectly to
cause LT-HSCs to enter active cell cycle; and (iv) chronic stimulation of LT-HSCs via this
pathway leads to their exhaustion through loss of quiescence. Our model also suggests that
intermediary progenitors which we show accumulate in BM during chronic infection may be
less efficient at producing mature progeny (ineffective hematopoiesis), but we have not specifi-
cally addressed whether this reflects an intrinsic defect or a further consequence of residence
in an environment chronically exposed to cytokines such as TNF and IFNč. Recent studies by
others have, for example, shown that stress-induced hematopoiesis promoted by chronic pro-
inflammatory conditions results in DNA damage that impaired the differentiation of mature
functional progeny [39].
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Given the well-established role of CD4+ T cell-derived IFNč in in the control of the parasite
burden in VL [59, 60], that we confirmed in the present study, there is likely to be a trade-off
between on the one hand the need for an effective anti-parasitic response to control primary
infection versus on the other hand the potential for longer term and irreversible damage to
hematopoietic fitness. The importance of this immunopathological sequela for the long-term
health of patients faced with continued pathogen insult over their life course remains to be
evaluated.
Materials and methods
Ethics statement
All animal experiments were carried out in accordance with the Animals and Scientific Pro-
cedures Act 1986, under UK Home Office Licence (project licence number PPL 60/4377
approved by the University of York Animal Welfare and Ethics Review Board), and conformed
to ARRIVE guidelines. Animals were killed by CO2 asphyxia and cervical dislocation.
Animal and infections
B6.CD45.1, B6.CD45.2, (B6.CD45.1xCD45.2)F1, B6.EYFP.Rag1-/- and B6.Rag2-/-.CD45.1Cg
were used in this study, bred and maintained under specific-pathogen free (SPF) conditions at
the Biological Services Facility, University of York. BM cells from mice lacking the Ifngr2 gene
(IFNč-R2 KO) on a B6 background were generously provided by Dr. Grainger (University of
Manchester, UK) [61]. BM cells from TNF receptor double KOmice (Tnfrsf1-dKO B6.129S
mice) [62] backcrossed>10 generations to C57BL/6 mice were provided by Dr. Lindbom
(Lund University, Sweden). IFNč-KO (B6.129S7-Ifngtm1Ts/J, stock no. 002287) mice were
obtained from the Jackson Laboratory. All mice were between 5–8 weeks of age at the start of
experimental work. Mice were infected via the lateral tail vein with 3x107 amastigotes of the
Ethiopian strain of L. donovani (LV9) or tandem Tomato fluorescent protein expressing L.
donovani (tdTom-L. donovani). Spleen parasite burden was expressed as Leishman-Donovani
units (LDU), where LDU was equal to the number of parasites/1000 host nuclei multiplied by
the organ weight in milligrams. BM parasite burden was determined as the number of para-
sites/1000 host nuclei.
Cell isolations and phenotypic characterization
Cell suspensions from spleen and BM (tibias and fibulas) were obtained as described previ-
ously [21]. For phenotypic analysis and FACS (Fluorescence-activated cell sorting) purifica-
tion, BM cells and splenocytes were stained with a lineage marker cocktail (CD3e (145-2C11),
Ly-6G and Ly-6C (RB6-8C5), TER-119 (TER-119), CD45R (RA3-6B2), and CD11b (M1/70)),
Sca1 (D7), cKit (2B8), CD48 (HM48-1), CD34 (RAM34), FLT3 (A2F10), IL-7Rċ (A7R34),
CD45 (30-F11), CD150 (TC15-12F12.2), CD45.1 (A20), CD45.2 (104), CD3e (145-2C11 and
UCHT1), CD4 (RM4-5 and 4SM95), CD8Č (H35-17.2), CD11c (N418), CD11b (M1/70),
MHC-II (M5/114.15.2), F4/80 (BM8), CD16/32 (93), TNFR1a (TR75-89), TNFR1b (55R-286),
TNF (MP6-XT22), IFNč (XMG1.2), GATA3 (16E10A23), Ki67 (MOPC-21), CD62L (MEL-
14), CD44 (IM7), Ly6C (AL-21), TCRčĎ (GL3) and CD49b (DX5). HSPCs were assigned
based on criteria shown in S1 Table. Negative controls were stained with matched-isotype
controls and dead cells were excluded using LIVE/DEAD Fixable Dead Cell Stains (Thermo
Fisher Scientific). For intracellular staining with cytokines cell suspensions were stimulated
with Phorbol-12-myristate-13-acetate (PMA) (Sigma-Aldrich) and ionomycin (Sigma-Aldrich)
[63]. Analyses were performed either in the BD LSR Fortessa X-20 (BD Biosciences) or the
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CyAn ADP analyser (Beckman Coulter). MoFlo Astrios (Beckman Coulter) was used to per-
form sorting (to> 95% purity). Data was analysed with FlowJo software (TreeStar).
Adoptive transfers and serial transfer of HSCs
BM cells from primary donors or from previously chimeric mice were sort purified as CD45+ Lin-
Sca1+ cKit+ CD150+ CD48-CD34- cells (LT-HSCs) or CD45+ Lin- cells (enriched for HSPCs) and
transplanted into lethally irradiated recipient mice (two doses of 550 rad, 24h apart). In non-com-
petitive adoptive transfer experiments, radio-protective BM cells were transferred together with
the sorted donor cells. For mixed BM chimeras, recipients received 1x106 BM cells from each
donor strain post-irradiation. Mice were infected at 7–9 weeks of chimerism. For the transplant of
CD4+ T cells, 6x105 of sort-purified splenic CD45+CD4+CD3+CD8-B220-TCRčĎ-CD49b- cells
were transplanted into B6.Rag2-/-.CD45.1Cg recipient mice.
Statistical analysis
Statistical analyses were performed by parametric or non-parametric tests, selected based on
the distribution of the raw data. The comparisons between experimental groups were per-
formed using student Unpaired t test, Mann-Whitney and one-way ANOVA. The analysis of
population distribution was performed using Chi-square test. All analyses were conducted
using GraphPad InStat (version 6) software (GraphPad).
Supporting information
S1 Fig. HSPCs from infected mice showed impaired engraftment in BM and decreased
reconstitution of the periphery. Relates to Fig 2A–2D (A), representative dot plots of gating
strategy used to segregate between recipient (CD45.1) and donor cells (CD45.2)!B6.CD45.1
x CD45.2F1 chimeras; control (left), transplanted (right). Relates to Fig 2E and 2F, (B) fre-
quency of mature splenic haematopoietic cells within donor cells in recipient mice 16 weeks
after transfer of 160 CD45.2 LT-HSCs (LSK CD150+ CD34- CD48-) purified from naive (light
squares) or day 28 infected (dark grey squares) mice. Relates to Fig 2G and 2H; analysis per-
formed 24 weeks after transplant into B6 CD45.1 lethally irradiated mice of radiation protec-
tive total BM cells (3.5x105) and 50 CD45.2 HSCs (LSK CD150+ CD34- CD48- cells) sort
purified from CD45.1 recipient mice previously adoptively transferred with CD45.2 HSCs
from mice naive or day 28 infected mice to lethally irradiated CD45.1 recipient mice for 16
weeks: (C) number of CMPs, GMPs, MEPs and CLPs within each donor compartment in the
BM of non-infected recipient mice, (D) number of mature hematopoietic cells: B cells, T cells
and CD11b+ cells (myeloid cells) within donor cells in the spleen of recipient mice. Absolute
numbers were calculated from two femurs and two tibias for each mouse. Data shown as scat-
ter plot and mean bar. Comparisons were made between naive donor cells (n = 4) and infected
donor cells (n = 3–4). p values were determined using unpaired t test: p 0.05, p0.01,
p0.001. (E) Representative dot plots gated in BM lineageneg cells (left) and LT-HSCs
(right) to assess parasite infection in mice infected for 28 days with LV9.TdTom (n = 5).
(TIF)
S2 Fig. Enhanced proliferation of HSCs was associated with increased levels of GATA-3
following L. donovani infection. (A) Representative dot plots of gating to select GATA-3+
cells in LSK CD150+ cells (enriched for non-committed progenitors). (B) Frequency of cells
expressing Ki67 and GATA-3 within LSK CD150+ CD48- cells (enriched for LT-HSCs). Data
from two independent experiments (n = 8 per group) presented as scatter plot and mean bar; p
values were determined using unpaired t test: p 0.05, p0.01, p0.001. (C)
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Frequency distribution of LSK CD150+ CD48- sub populations based on Ki67 and GATA-3
expression. Mean from two independent experiments (n = 8 per group): p 0.05, p0.01,
p0.001, p0.0001; Chi-square test.
(TIF)
S3 Fig. Lack of intrinsic IFNč receptor signalling affects development of CD11b+F4/80hi
cells following infection. Relates to Fig 7 (A) Frequency of BM lineage-committed progeni-
tors in naïve (light symbols) and infected (dark grey symbols) mice derived from HSCs of B6.
WT or B6.IFNčR2−/− origin (squares and triangles, respectively). (B-E) Frequencies of: BM B
cells (B), BMmyeloid subsets (C), splenic B cells (D), and splenic myeloid cells (E) within
each donor population. Analyses were performed 12 weeks after transplant of BM cells from
CD45.2 Ifnčr2−/−mice and CD45.1 WTmice (50:50) to lethally irradiated CD45.1 recipients.
Data was presented as scatter plot and mean bar (n = 4 per group); p 0.05, p0.01, p
0.001 and p0.0001; One-way Anova followed by Tukey’s multiple comparisons test.
(TIF)
S4 Fig. TNFR expression increases on BM cells following L. donovani infection. Relates to
Fig 8 (A) Frequency of BM CD45+ Lineage+ cells and Lineage- cKit+ cells expressing TNFR1a.
(b) Frequency of BM HSPCs populations expressing TNF-R1a. (c) MFI of TNF-R1a on
HSPCs. (D) Representative histogram of TNF-R1a expression on LSK CD150+ cells. (E) Fre-
quency of BM CD45+ Lineage+ cells and Lineage- cKit+ cells expressing TNF-R1b. (F) Fre-
quency of BM HSPCs populations expressing TNF-R1b (G) MFI of TNF-R1b expression on
HSPCs. (H) Representative histogram of TNF-R1b expression on LSK CD150+ cells. Data
from one experiment as Mean ± SD (n = 5 per group); p 0.05, p0.01, p0.001 and
p0.0001; unpaired t test.
(TIF)
S5 Fig. TNF receptor signalling is not required for B cell and myeloid cell development.
Relates to Fig 8. (A) Frequency of lineage-committed progenitors, (B) B cells and CD11b+ cells
in the BM of naïve and infected recipient mice derived from HSCs of B6.WT (squares) or B6
Tnfrsf1-dKO (triangle) origin within donor cells. (C) Frequency of myeloid cells, (D) B cells (E)
and T cells in the spleen of naïve and infected recipient mice derived fromHSCs of B6.WT or
B6 Tnfrsf1-dKO origin within donor cells. (F) Number of T cells in the spleen of recipient mice
derived fromHSCs of B6.WT or B6 Tnfrsf1-dKO origin within donor cells. Analyses were per-
formed 13 weeks after transplant of BM cells from CD45.2 TNFRdKOmice and CD45.1 WT
mice (50:50) to lethally irradiated CD45.1 recipients. Data from two independent experiments
was presented as Scatter-plot and mean (n = 8–9 per group); p 0.05, p0.01, p0.001
and p0.0001; One-way Anova followed by Tukey’s multiple comparisons test.
(TIF)
S6 Fig. Proposed model for development of pathogenic BM CD4+ T cells. Following L.
donovani infection, proliferating LT-HSCs and onward multipotent progenitors expand
greatly at the expense of LT-HSCs in G0, leading to functional exhaustion, as demonstrated by
serial transfer. CD4+ T cells mediate LT-HSC exhaustion through an INFč-dependent mecha-
nism. However, the expansion of pathogenic CD4+ T cells secreting INFč+ is limited in the
absence of T cell-intrinsic TNF receptor signaling, indicating that TNF indirectly modulates
LT-HSCs exhaustion during chronic infection in L. donovani.
(TIF)
S1 Table. Surface markers used to characterize HSPCs by flow cytometry analysis.
(TIF)
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